Related Experiment Videos
Critical point mutations for hepatitis C virus NS3 proteinase
1Molecular Medicine Laboratory, Yokohama Research Center, Mitsubishi Chemical Corp., Japan.
Virology
|July 10, 1998
Summary
Researchers developed a trans-cleavage assay to study the hepatitis C virus (HCV) NS3 proteinase. This assay identified critical mutations affecting enzyme activity, crucial for understanding HCV replication.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- The hepatitis C virus (HCV) NS3 proteinase is vital for viral polyprotein processing.
- Understanding NS3 proteinase function is key to developing antiviral therapies.
Purpose of the Study:
- To develop a novel assay for detecting HCV NS3 proteinase activity.
- To identify functional domains and critical mutations within the NS3 proteinase.
Main Methods:
- A trans-cleavage assay was established using co-expressed recombinant plasmids in E. coli.
- Deletion analysis determined the minimal functional domain of the NS3 proteinase.
- cDNA clones from HCV patients were analyzed for proteinase activity and sequence variations.
Main Results:
- The minimal functional domain of NS3 proteinase spans 146 amino acids (1059-1204).
- Both active and inactive NS3 proteinase clones were found in the same HCV-infected patients.
- Specific point mutations, including Pro-1168 to Thr and Arg-1135 to Gly, were linked to loss of proteolytic activity.
Conclusions:
- The developed trans-cleavage assay effectively measures NS3 proteinase activity.
- Mutations near the active site's oxyanion hole significantly impact NS3 proteinase conformation and function.
- These findings provide insights into HCV genetic diversity and potential therapeutic targets.